Highlights and Quick Summary
- Change in Cash for the quarter ending September 30, 2023 was $-76.6 Million (a 494.63% increase compared to previous quarter)
- Year-over-year quarterly Change in Cash decreased by -154.86%
- Annual Change in Cash for 2022 was $2.57 Million (a -98.41% decrease from previous year)
- Annual Change in Cash for 2021 was $162 Million (a 470.35% increase from previous year)
- Annual Change in Cash for 2020 was $28.3 Million (a 227.6% increase from previous year)
- Twelve month Change in Cash ending September 30, 2023 was $-3.99 Million (a -114.07% decrease compared to previous quarter)
- Twelve month trailing Change in Cash decreased by -255.11% year-over-year
Trailing Change in Cash for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $-3.99 Million | $28.3 Million | $-30.4 Million | $2.57 Million |
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Change in Cash of Prime Medicine, Inc.
Most recent Change in Cashof PRME including historical data for past 10 years.Interactive Chart of Change in Cash of Prime Medicine, Inc.
Prime Medicine, Inc. Change in Cash for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-76.62 | $-12.89 | $-54.16 | – | – |
| 2022 | $139.67 | $-44.29 | $-71.64 | $-21.17 | $2.57 |
| 2021 | – | – | $-2.12 | $163.69 | $161.57 |
| 2020 | – | – | – | $28.33 | $28.33 |
| 2019 | – | – | – | – | $8.65 |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology